The market for Glucagon-like peptide-1 analogues is predicted to develop because to the high prevale
Riya_pahuja_14 Sep, 2021Miscellaneous
According to the International Diabetes Federation's (IDF) Diabetes Atlas 2017, diabetes affects over 425 million people globally. According to a 2017 World Health Organization (WHO) report, diabetes is one of the top three noncommunicable illness causes of death. The top three economies with a high incidence of diabetes are China (114.4 million), India (72.9 million), and the United States (30.2 million). The Glucagon-like peptide-1 analogs market would have a huge growth opportunity with such a high incidence rate. This is due to the fact that there are roughly 212.4 million people living with undiagnosed diabetes worldwide
Related Bookmarks
- Reasons to hire a professional house maintenance company
- What are the advantages of hiring professional aircraft appraiser?
- Top Benefits of Beard Shampoo that you should know
- Asia Pacific is expected to be the largest and fastest growing region for Metallocene Polyethylene M
- The global outsourced drug discovery market is expected to grow at a CAGR of 12.1 percent between 20
- The global beauty supplements market is expected to reach US$ 7,100 Mn by 2023
- The Global Regulatory Information Management System (RIMS) market is expected to grow at a significa
- Odoo ERP Software Development For The Insurance Industry
- Better awareness among women is driving the growth of the Bath Bombs Market
- Monochloroacetic Acid (MCAA) Market is expected to reach USD 908.9 million by 2022
Recent Profiles
566
Congadenmont
Dunn Kaas
Steensen Gonzales
Mendez Korsholm
Abernathy Huang
Puggaard Erichsen
Poe Langston
Ryberg Lillelund
Hald Hardin